Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Flow-Cytometry MRD Evaluation in Children with ALL; Can MRD Level on Day 33 Serve As a Surrogate Marker for Relapse?

Maria Ampatzidou, MD, George Paterakis, MD PhD, Konstantinos Tsitsikas, Stephanos I. Papadhimitriou, MD PhD, Vassilios Papadakis, MD PhD, Vassilios Vasdekis, Loizos Petrikkos, MD, Sophia Polychronopoulou, MD PhD

Blood (2014) 124 (21): 2401.

https://doi.org/10.1182/blood.V124.21.2401.2401

Published: 2014

Journal Articles

ETV6/RUNX1-Postitive Childhood Acute Lymphoblastic Leukemia (ALL): Do Additional Aberrations Influence Treatment Response and Outcome?

Maria Ampatzidou, Stephanos I. Papadhimitriou, MD PhD, George Paterakis, MD PhD, Loizos Petrikkos, MD, Dimitrios Pavlidis, Konstantinos Tsitsikas, Vassilios Papadakis, MD PhD, George Vassilopoulos, MD PhD, Sophia Polychronopoulou, MD PhD

Blood (2014) 124 (21): 2403.

https://doi.org/10.1182/blood.V124.21.2403.2403

Published: 2014

Journal Articles

MLL Rearrangements in Childhood Acute Lymphoblastic Leukemia: Clinical and Genetic Features of a Distinct Disease Entity

Maria Ampatzidou, MD, Stephanos I. Papadhimitriou, MD PhD, Loizos Petrikkos, MD, Dimitrios Pavlidis, Konstantinos Tsitsikas, Vassilios Papadakis, MD PhD, George Paterakis, MD PhD, Sophia Polychronopoulou, MD PhD

Blood (2014) 124 (21): 5355.

https://doi.org/10.1182/blood.V124.21.5355.5355

Published: 2014

Journal Articles

The Experience on Multiparametric Molecular Diagnostic Approach of Pediatric Acute Lymphoblastic Leukemia (ALL) in Greece.

Agapi Parcharidou, MD,PhD, Constantina Sambani, PhD, Christina Stavropoulou, PhD, George Paterakis, MD,PhD, Chrysoula Belesi, PhD, Stefanos Papadhimitriou, MD,PhD, Constantinos Tsitsikas, PhD, Vassilios Georgakakos, PhD, Vassilios Papadakis, MD,PhD, Sophia Polychronopoulou, MD,PhD

Blood (2006) 108 (11): 4448.

https://doi.org/10.1182/blood.V108.11.4448.4448

Published: 2006

Journal Articles

Late Appearance of t(9;22) at Relapse, in an Adolescent with an Homozygous 9p Deletion T-ALL.

Vassilios Papadakis, MD, PhD, Stefanos Papadhimitriou, MD, PhD, Anna Paisiou, MD, Chrysoula Belesi, PhD, Agapi Parcharidou, MD, PhD, Natalia Tourkantoni, MD, Constantina Sambani, PhD, George Paterakis, MD, PhD, Sophia Polychronopoulou, MD, PhD

Blood (2006) 108 (11): 4458.

https://doi.org/10.1182/blood.V108.11.4458.4458

Published: 2006

Journal Articles

t(8;21) Positive AML with Favorable Clinical Characteristics, in a Child with Ependymoma after Combined Treatment with Neuroaxis Irradiation and Topoisomerase II Inhibitors.

Vassilios Papadakis, MD, PhD, Stefanos Papadhimitriou, MD, PhD, Anna Paisiou, MD, Agapi Parcharidou, MD,PhD, Natalia Tourkantoni, MD, George Paterakis, MD, PhD, Chrysoula Belesi, PhD, Constantina Sambani, PhD, Sophia Polychronopoulou, MD, PhD

Blood (2006) 108 (11): 4511.

https://doi.org/10.1182/blood.V108.11.4511.4511

Published: 2006

NARROW

Flow-Cytometry MRD Evaluation in Children with ALL; Can MRD Level on Day 33 Serve As a Surrogate Marker for Relapse?

ETV6/RUNX1-Postitive Childhood Acute Lymphoblastic Leukemia (ALL): Do Additional Aberrations Influence Treatment Response and Outcome?

MLL Rearrangements in Childhood Acute Lymphoblastic Leukemia: Clinical and Genetic Features of a Distinct Disease Entity

The Experience on Multiparametric Molecular Diagnostic Approach of Pediatric Acute Lymphoblastic Leukemia (ALL) in Greece.

Late Appearance of t(9;22) at Relapse, in an Adolescent with an Homozygous 9p Deletion T-ALL.

t(8;21) Positive AML with Favorable Clinical Characteristics, in a Child with Ependymoma after Combined Treatment with Neuroaxis Irradiation and Topoisomerase II Inhibitors.

Email alerts

ASH Publications

American Society of Hematology

Flow-Cytometry MRD Evaluation in Children with ALL; Can MRD Level on Day 33 Serve As a Surrogate Marker for Relapse?

ETV6/RUNX1-Postitive Childhood Acute Lymphoblastic Leukemia (ALL): Do Additional Aberrations Influence Treatment Response and Outcome?

MLL Rearrangements in Childhood Acute Lymphoblastic Leukemia: Clinical and Genetic Features of a Distinct Disease Entity

The Experience on Multiparametric Molecular Diagnostic Approach of Pediatric Acute Lymphoblastic Leukemia (ALL) in Greece.

Late Appearance of t(9;22) at Relapse, in an Adolescent with an Homozygous 9p Deletion T-ALL.

t(8;21) Positive AML with Favorable Clinical Characteristics, in a Child with Ependymoma after Combined Treatment with Neuroaxis Irradiation and Topoisomerase II Inhibitors.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only